Recently, both the frequency and prognostic manifestation of mutations in NOTCH1 and FBXW7 were investigated in patients of Swedish childhood T‐ALL treated according to the Nordic Society of Pediatric Hematology and Oncology (NOPHO) ALL‐1992 and ALL‐2000 protocols. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.